Showing results (51-60 of 541) with videos related to
Sort By:
Pageof 55
Drugs - Real World Outcomes|November 5, 2020
Association Between Adverse Events and Discontinuation of Antiepileptic Drugs Among Drug-Naïve Adults with EpilepsySamuel K Peasah, Jesse Fishman, Derek Ems, et al.Drugs - Real World Outcomes|January 7, 2018
Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?Kathleen A Fairman, Lindsay E Davis, Alyssa M Peckham, et al.Drugs - Real World Outcomes|May 16, 2022
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation StudyDonica Janzen, Reece Ramkissoon, James M Bolton, et al.Drugs - Real World Outcomes|May 17, 2022
Polypharmacy in Australian Veterans with Post-traumatic Stress Disorder upon Admission to a Mental Health Facility: A Retrospective Chart ReviewRebecca Mellor, Andrew Khoo, Elise Saunders-Dow, et al.Drugs - Real World Outcomes|July 18, 2021
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)Chengwen Teng, Christopher R FreiDrugs - Real World Outcomes|December 4, 2019
Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary DiseaseMelissa H Roberts, Douglas W Mapel, Hans PetersenDrugs - Real World Outcomes|December 14, 2021
Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South KoreaDiego Novick, Jae Min Cho, Sam Colman, et al.Drugs - Real World Outcomes|November 15, 2021
Real-World Use and Outcomes of Oral Antiplatelets Among Patients with Acute Coronary Syndrome: A Retrospective Cohort StudySamuel K Peasah, Douglas Mager, Kiraat D Munshi, et al.Drugs - Real World Outcomes|October 15, 2022
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis RegistryPhilip J Mease, Alexis Ogdie, Soumya D Chakravarty, et al.Drugs - Real World Outcomes|November 5, 2022
Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World SettingSeiji Yokoyama, Yutaka Ishii, Junya MasudaPageof 55